ストックスクリーナーアプリを入手
2.57
3.01%
-0.09
アフターアワーズ：
2.54
-0.03
-1.17%
前日終値:
$2.66
開ける：
$2.6
24時間の取引高:
13,141
Relative Volume:
0.01
時価総額：
$4.61M
収益：
-
当期純損益:
$-4.14M
株価収益率:
-0.3544
EPS:
-7.2511
ネットキャッシュフロー:
$-4.79M
1週間 パフォーマンス:
-4.44%
1か月 パフォーマンス:
+20.56%
6か月 パフォーマンス:
-35.85%
1年 パフォーマンス:
-77.13%
1日の値動き範囲:
$2.54
$2.70
1週間の範囲:
$2.33
$2.759
52週間の値動き範囲:
$1.9501
$13.80
Bone Biologics Corp Stock (BBLG) Company Profile
名前
Bone Biologics Corp
セクター
電話
(781) 552-4452
住所
2 BURLINGTON WOODS DRIVE,, BURLINGTON
BBLG を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BBLG
Bone Biologics Corp
|
2.57 | 4.61M | 0 | -4.14M | -4.79M | -7.2511 |
|
ABT
Abbott Laboratories
|
127.62 | 231.95B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
BSX
Boston Scientific Corp
|
97.78 | 142.60B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
369.25 | 141.45B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
95.03 | 123.83B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
72.64 | 43.07B | 5.69B | 1.41B | 577.90M | 6.9828 |
Bone Biologics Corp (BBLG) 最新ニュース
Can trapped investors hope for a rebound in Bone Biologics Corporation Equity WarrantInsider Buying & Expert-Curated Trade Recommendations - newser.com
Bone Biologics (NASDAQ:BBLG) Receives “Sell (E+)” Rating from Weiss Ratings - Defense World
Applying Wyckoff theory to Bone Biologics Corporation Equity Warrant stockFed Meeting & High Conviction Trade Alerts - newser.com
How sentiment analysis helps forecast Bone Biologics CorporationPortfolio Value Report & Safe Entry Momentum Tips - newser.com
Will Bone Biologics Corporation Equity Warrant stock gain from lower inflationPrice Action & Risk Managed Investment Signals - newser.com
Is now a turning point for Bone Biologics Corporation2025 Analyst Calls & Daily Technical Forecast Reports - newser.com
Measuring Bone Biologics Corporation’s beta against major indicesAnalyst Downgrade & Weekly Setup with ROI Potential - newser.com
Keensight Capital Acquires Majority Stake in Isto Biologics, a Leading Orthobiologics Player, from Thompson Street Capital Partners - Norwich Bulletin
Is Bone Biologics Corporation a good long term investmentEmerging Market Stocks & Investment Portfolio Recommendations - earlytimes.in
Key metrics from Bone Biologics Corporation’s quarterly dataJuly 2025 PreEarnings & AI Enhanced Trading Alerts - newser.com
Why Bone Biologics Corporation Equity Warrant stock remains resilientQuarterly Market Summary & Weekly Chart Analysis and Guides - newser.com
Why Bone Biologics Corporation stock attracts global investorsJuly 2025 Rallies & AI Powered Market Entry Strategies - newser.com
Can Bone Biologics Corporation stock outperform in 2025 bull marketGap Down & Free High Accuracy Swing Entry Alerts - newser.com
Bone Biologics (OTC:BBLG) Trading Down 8.6% – Should You Sell? - Defense World
Will Bone Biologics Corporation Equity Warrant continue its uptrendQuarterly Growth Report & Free Reliable Trade Execution Plans - newser.com
What recovery options are there for Bone Biologics CorporationCEO Change & Weekly Watchlist for Hot Stocks - newser.com
Biocon Biologics Secures U.S. Market Entry Date for Bosaya™ and Aukelso™, Denosumab Biosimilars - Yahoo Finance
The United States Orthobiologics Market offers significant growth opportunities in segments like Cartilage Repair, Bone Grafts and Substitutes, Bone Growth Stimulators, Soft Tissue Biologics, and Viscosupplementation. Key companies and strategic insights e - Ortho Spine News
Will Bone Biologics Corporation Equity Warrant bounce back from current supportMarket Risk Summary & Daily Profit Focused Screening - newser.com
How to track smart money flows in Bone Biologics CorporationEarnings Miss & Real-Time Volume Triggers - newser.com
How to read the order book for Bone Biologics Corporation Equity WarrantShare Buyback & Daily Volume Surge Trade Alerts - newser.com
Can Bone Biologics Corporation recover in the next quarterProduct Launch & Daily Profit Maximizing Tips - newser.com
Why Bone Biologics Corporation Equity Warrant is moving today2025 Volume Leaders & Accurate Technical Buy Alerts - newser.com
Will Bone Biologics Corporation stock rally after Fed decisionsWeekly Trade Analysis & Scalable Portfolio Growth Ideas - newser.com
Bone Biologics (NASDAQ:BBLG) Upgraded by Wall Street Zen to Hold Rating - Defense World
Smart tools for monitoring Bone Biologics Corporation’s price action2025 Key Highlights & Stepwise Swing Trade Plans - newser.com
How Enterprise Financial Services Corp (GV9) stock trades after rate cuts2025 Short Interest & Verified Short-Term Trading Plans - newser.com
Will QDEC stock keep high P E multiplesMarket Risk Report & Reliable Intraday Trade Alerts - newser.com
Is Anavex Life Sciences Corp. (12X1) stock testing key supportDay Trade & Community Consensus Stock Picks - newser.com
Is Bone Biologics Corporation forming a bottoming baseJuly 2025 Weekly Recap & Community Supported Trade Ideas - newser.com
Ranking Bone Biologics Corporation among high performing stocks via tools2025 Top Decliners & AI Driven Stock Reports - newser.com
Orthobiologics Market: Sales Volume, Size, Share, Price Development Trend Forecast Report 2025-2035 - Vantage Market Research
Live market analysis of Bone Biologics Corporation Equity WarrantEarnings Growth Report & Risk Managed Investment Entry Signals - newser.com
Real time pattern detection on Bone Biologics Corporation Equity Warrant stockDividend Hike & Weekly Breakout Watchlists - newser.com
Will BMRN outperform the marketJuly 2025 Movers & Precise Swing Trade Entry Alerts - newser.com
Can trapped investors hope for a rebound in Bone Biologics CorporationJuly 2025 Breakouts & Capital Protection Trading Alerts - newser.com
Best data tools to analyze Bone Biologics Corporation stock2025 Fundamental Recap & Consistent Profit Alerts - newser.com
Bone Biologics Corp (BBLG) 財務データ
収益
当期純利益
現金流量
EPS
1.24%
0.36%
大文字化:
|
ボリューム (24 時間):